↓ Skip to main content

The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

Overview of attention for article published in The Lancet, July 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Citations

dimensions_citation
1113 Dimensions

Readers on

mendeley
937 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Published in
The Lancet, July 2016
DOI 10.1016/s0140-6736(16)30579-7
Pubmed ID
Authors

Jeffrey D Stanaway, Abraham D Flaxman, Mohsen Naghavi, Christina Fitzmaurice, Theo Vos, Ibrahim Abubakar, Laith J Abu-Raddad, Reza Assadi, Neeraj Bhala, Benjamin Cowie, Mohammad H Forouzanfour, Justina Groeger, Khayriyyah Mohd Hanafiah, Kathryn H Jacobsen, Spencer L James, Jennifer MacLachlan, Reza Malekzadeh, Natasha K Martin, Ali A Mokdad, Ali H Mokdad, Christopher J L Murray, Dietrich Plass, Saleem Rana, David B Rein, Jan Hendrik Richardus, Juan Sanabria, Mete Saylan, Saeid Shahraz, Samuel So, Vasiliy V Vlassov, Elisabete Weiderpass, Steven T Wiersma, Mustafa Younis, Chuanhua Yu, Maysaa El Sayed Zaki, Graham S Cooke

Abstract

With recent improvements in vaccines and treatments against viral hepatitis, an improved understanding of the burden of viral hepatitis is needed to inform global intervention strategies. We used data from the Global Burden of Disease (GBD) Study to estimate morbidity and mortality for acute viral hepatitis, and for cirrhosis and liver cancer caused by viral hepatitis, by age, sex, and country from 1990 to 2013. We estimated mortality using natural history models for acute hepatitis infections and GBD's cause-of-death ensemble model for cirrhosis and liver cancer. We used meta-regression to estimate total cirrhosis and total liver cancer prevalence, as well as the proportion of cirrhosis and liver cancer attributable to each cause. We then estimated cause-specific prevalence as the product of the total prevalence and the proportion attributable to a specific cause. Disability-adjusted life-years (DALYs) were calculated as the sum of years of life lost (YLLs) and years lived with disability (YLDs). Between 1990 and 2013, global viral hepatitis deaths increased from 0·89 million (95% uncertainty interval [UI] 0·86-0·94) to 1·45 million (1·38-1·54); YLLs from 31·0 million (29·6-32·6) to 41·6 million (39·1-44·7); YLDs from 0·65 million (0·45-0·89) to 0·87 million (0·61-1·18); and DALYs from 31·7 million (30·2-33·3) to 42·5 million (39·9-45·6). In 2013, viral hepatitis was the seventh (95% UI seventh to eighth) leading cause of death worldwide, compared with tenth (tenth to 12th) in 1990. Viral hepatitis is a leading cause of death and disability worldwide. Unlike most communicable diseases, the absolute burden and relative rank of viral hepatitis increased between 1990 and 2013. The enormous health loss attributable to viral hepatitis, and the availability of effective vaccines and treatments, suggests an important opportunity to improve public health. Bill & Melinda Gates Foundation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 334 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 937 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 <1%
Portugal 1 <1%
Israel 1 <1%
Canada 1 <1%
India 1 <1%
Japan 1 <1%
Peru 1 <1%
Unknown 928 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 149 16%
Researcher 120 13%
Student > Ph. D. Student 104 11%
Student > Bachelor 91 10%
Other 70 7%
Other 177 19%
Unknown 226 24%
Readers by discipline Count As %
Medicine and Dentistry 291 31%
Biochemistry, Genetics and Molecular Biology 70 7%
Immunology and Microbiology 66 7%
Nursing and Health Professions 51 5%
Agricultural and Biological Sciences 49 5%
Other 140 15%
Unknown 270 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1246. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2023.
All research outputs
#11,072
of 25,571,620 outputs
Outputs from The Lancet
#353
of 42,824 outputs
Outputs of similar age
#136
of 371,483 outputs
Outputs of similar age from The Lancet
#7
of 374 outputs
Altmetric has tracked 25,571,620 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,824 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,483 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 374 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.